There are a lot of stem cell blogs out there, some of them better than others… a LOT better. and some a lot worse. 😛 Paul Knoepfler’s blog is one of those at the head of the pack for sure, although I don’t always agree with everything he’s been publishing lately, especially the glowing, overly optimistic, heading-for-a-fall-IMHO coverage of Takahashi and her iPSC cell based RPE work in Japan. (You know, the one where they’re moving terrifyingly fast and using humans as guinea pigs about a zillion times faster than they should have…) But anyway. We all have our own opinions. 🙂
It’s also good to branch out. And that’s why I’m recommending this link to msemporda’s blog!
The Amazing Stem Cell Science Blog. THIS, I tell you, is an expert. Stem cell science, sector analysis, biotech company analysis, news… he has it all. And he’s somehow able to keep from rants…. I can’t do that, and I admit it… So check it out. 🙂
I survived the disease, and I now have the only remission on record. But a remission is not a cure. The stem cell drug I need for a real cure is now rapidly moving towards approval in the rest of the world, but in the USA, it—and all other cellular therapies-- are still stuck behind prejudice, ignorance, and lack of funding. Hundreds of millions of desperate patients with incurable diseases need these drugs.
That’s why I’ve gone on to fight for greater public education on stem cell drugs, knowing that our laws must be changed so that all of us can get access to the best treatments instead of our health and our lives being held hostage by special interests.
I’m now a patient advocate whose work on stem cells and patients’ rights has been published in outlets such as the Oregonian. I am a manager at popular science and financial blog www.stemcellinvestor.com and a frequent speaker at many venues across the spectrum, including churches, scientific conferences, and atheist groups, and everything in between. I’m also an advocate for Right to Try laws that would allow access to experimental medication for terminal patients at the state level. Read the entire story in my upcoming book, And the Blind Shall See: A Skeptic Patient Surprised by Faith, Science, Family, and Miracle Cures.
Latest posts by Cathy Danielson (see all)
- A new story about shareholder determination! - January 21, 2016
- The Latest Thoughts on Why Ocata is Being Bought out by Astellas - November 29, 2015
- The Missing Word: Why we don’t have stem cell cures. - November 23, 2015